Boris Peaker
Stock Analyst at TD Cowen
(1.58)
# 2,340
Out of 4,667 analysts
22
Total ratings
20%
Success rate
41.06%
Average return
Main Sectors:
Stocks Rated by Boris Peaker
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AADI Aadi Bioscience | Downgrades: Hold | n/a | $2.22 | - | 2 | Aug 21, 2024 | |
| GLYC GlycoMimetics | Downgrades: Hold | n/a | $0.33 | - | 1 | Jul 26, 2024 | |
| MGNX MacroGenics | Downgrades: Hold | n/a | $3.28 | - | 3 | May 10, 2024 | |
| LNTH Lantheus Holdings | Initiates: Outperform | $100 | $86.45 | +15.67% | 1 | Dec 4, 2023 | |
| ADCT ADC Therapeutics | Downgrades: Market Perform | n/a | $1.98 | - | 1 | Nov 9, 2023 | |
| PCRX Pacira BioSciences | Upgrades: Outperform | $50 | $17.03 | +193.60% | 1 | Aug 3, 2023 | |
| PCVX Vaxcyte | Initiates: Outperform | n/a | $85.96 | - | 1 | Apr 18, 2023 | |
| XNCR Xencor | Initiates: Outperform | n/a | $23.72 | - | 1 | Dec 6, 2022 | |
| EBS Emergent BioSolutions | Maintains: Market Perform | $30 → $29 | $8.88 | +226.58% | 1 | Sep 12, 2022 | |
| CTMX CytomX Therapeutics | Downgrades: Market Perform | n/a | $0.87 | - | 2 | Jul 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $95 → $102 | $97.44 | +4.68% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.00 | - | 1 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $1.28 | - | 1 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.12 | - | 1 | Aug 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $12.78 | - | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.67 | - | 1 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $2.22 | - | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $591.82 | - | 1 | Jun 12, 2017 |
Aadi Bioscience
Aug 21, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.22
Upside: -
GlycoMimetics
Jul 26, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.33
Upside: -
MacroGenics
May 10, 2024
Downgrades: Hold
Price Target: n/a
Current: $3.28
Upside: -
Lantheus Holdings
Dec 4, 2023
Initiates: Outperform
Price Target: $100
Current: $86.45
Upside: +15.67%
ADC Therapeutics
Nov 9, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.98
Upside: -
Pacira BioSciences
Aug 3, 2023
Upgrades: Outperform
Price Target: $50
Current: $17.03
Upside: +193.60%
Vaxcyte
Apr 18, 2023
Initiates: Outperform
Price Target: n/a
Current: $85.96
Upside: -
Xencor
Dec 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $23.72
Upside: -
Emergent BioSolutions
Sep 12, 2022
Maintains: Market Perform
Price Target: $30 → $29
Current: $8.88
Upside: +226.58%
CytomX Therapeutics
Jul 11, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $0.87
Upside: -
Jun 27, 2022
Maintains: Market Perform
Price Target: $95 → $102
Current: $97.44
Upside: +4.68%
Mar 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.00
Upside: -
Mar 3, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $1.28
Upside: -
Aug 13, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.12
Upside: -
Jul 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $12.78
Upside: -
Oct 22, 2018
Initiates: Outperform
Price Target: n/a
Current: $2.67
Upside: -
Jul 24, 2017
Initiates: Outperform
Price Target: n/a
Current: $2.22
Upside: -
Jun 12, 2017
Initiates: Outperform
Price Target: n/a
Current: $591.82
Upside: -